Literature DB >> 22381918

Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection.

Giulia Campanini1, Maurizio Zavattoni, Emilio Cristina, Diego Gazzolo, Mauro Stronati, Fausto Baldanti.   

Abstract

A case of human cytomegalovirus (HCMV) drug-resistance in a congenitally infected newborn is described. Unusual aspects of this case include: (i) the detection of an extremely complex virus population, composed of a mixture of wild-type (wt) and multiple mutant ganciclovir (GCV) and valganciclovir (val-GCV) resistant strains carrying a variety of known mutations in UL97; (ii) the identification of novel UL97 mutations and (iii) the first time detection of combined UL97 drug resistance mutations in the same viral strain. In detail, four known UL97 single-nucleotide mutations (A594T/V, M460V/I, C592G), a new amino-acid substitution (C607S), and a new deletion (597-600) in one of the three UL97 hot spots for GCV/val-GCV resistance (codons 460, 520 and 590-607) were detected. In addition, the combination of M460V+A594V and M460V+C592G was observed for the first time. The emergence of HCMV drug-resistance in symptomatic congenital infections chronically treated with GCV or val-GCV should be taken into account. The immaturity of the neonatal immune system may contribute to selection of complex virus populations in these patients.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381918     DOI: 10.1016/j.jcv.2012.01.020

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  3 in total

1.  Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study.

Authors:  Yuka Torii; Kazuhiro Horiba; Jun-Ichi Kawada; Kazunori Haruta; Makoto Yamaguchi; Takako Suzuki; Hideko Uryu; Naoyuki Kashiwa; Keiji Goishi; Tomoo Ogi; Yoshinori Ito
Journal:  BMC Infect Dis       Date:  2022-06-22       Impact factor: 3.667

2.  Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.

Authors:  K Yeon Choi; B Sharon; H H Balfour; K Belani; T C Pozos; M R Schleiss
Journal:  J Clin Virol       Date:  2013-05-18       Impact factor: 3.168

Review 3.  Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: a case report and review of the literature.

Authors:  Beatriz Morillo-Gutierrez; Sheila Waugh; Ailsa Pickering; Terence Flood; Marieke Emonts
Journal:  BMC Pediatr       Date:  2017-08-22       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.